No Data
No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Sonoma Pharmaceuticals (SNOA) Gains In Pre-Hour Trading
New York Manufacturing Hits Low, Inflation Fears Rise
What's Going On With Sonoma Pharmaceuticals Stock Tuesday?
Wall Street Stabilizes, Driving Quiet Premarket Action for US Equity Futures
Express News | Sonoma Pharmaceuticals is up over 50% in pre-market trading after receiving regulatory approval from the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) for its critical wound care and dermatology products.